Clinical Trial Update: IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid Arthritis

View source ↗

Summary

A Pfizer-sponsored clinical trial on tofacitinib in rheumatoid arthritis identified factors predictive of patient survival; the study has completed and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tofacitinib (tofacitinib)
• XELJANZ (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Status: COMPLETED | Results posted: 2024-10-01